# High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

> **NCT00002465** · PHASE1,PHASE2 · UNKNOWN · sponsor: **St. Vincent Medical Center - Los Angeles**

## Conditions studied

- Breast Cancer
- Endometrial Cancer
- Malignant Mesothelioma

## Interventions

- **DRUG:** megestrol acetate

## Key facts

- **NCT ID:** NCT00002465
- **Lead sponsor:** St. Vincent Medical Center - Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1987-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002465, "High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00002465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*